Every Form 4 that UnitedHealth Group Incorporated (UNH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow UNH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UNH filings page.
UNITEDHEALTH GROUP INC director Charles D. Baker reported a small share award. On March 17, 2026, he acquired 14 shares of Common Stock at a price of $0.00 per share as a grant/award acquisition.
According to the footnote, these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. After this transaction, Baker directly holds 1,820 shares of UnitedHealth Group common stock.
UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, reported an acquisition of company common stock through a share-based award. She received 64.885 shares as dividend equivalents on outstanding restricted stock units at a stated price of $0.00 per share.
These dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this award, McSweeney directly holds a reported total of 15,552.923 UnitedHealth Group common shares.
UNITEDHEALTH GROUP INC director Michele J. Hooper received 292 shares of common stock as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units, meaning they function as routine, compensation-related accruals rather than an open-market purchase. After this acquisition, Hooper directly holds a total of 41,586 shares of UnitedHealth Group common stock, indicating this is a small, incremental increase to an existing position.
UNITEDHEALTH GROUP INC director Kristen Gil reported a small stock award. On March 17, 2026, Gil acquired 8 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units and subject to the same terms as those units. After this award, Gil holds 2,083 shares directly and 3,800 shares indirectly through a trust, indicating this is a routine, compensation-related update rather than an open-market trade.
UNITEDHEALTH GROUP INC director Scott Gottlieb reported a small compensation-related equity acquisition. He received 1 share-equivalent of common stock on 2026-03-17 as dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this award, he directly owns 126 shares of common stock.
Conway Patrick Hugh reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC reported that Patrick Hugh Conway, Chief Executive Officer of Optum, received a grant of 125.021 shares of common stock on March 17, 2026 at a price of $0.00 per share. These shares represent dividend equivalents on his outstanding restricted stock units and will vest or be forfeited under the same conditions as those units. Following this award, his directly held common stock position increased to 18,604.991 shares, indicating a routine, compensation-related adjustment rather than an open-market purchase.
UNITEDHEALTH GROUP INC Chief Accounting Officer Thomas E. Roos reported several equity-related transactions on common stock and options. He was granted 9,768 non-qualified stock options with an exercise right to buy shares, all recorded at a price of $0.0000 per option. He also acquired 2,436 shares of common stock through a grant or award and had 151.777 shares of common stock disposed of to cover tax obligations at $282.3400 per share. Following these transactions, his directly held common stock position increased to 31,283.641 shares. The non-qualified stock options vest 25% each year on February 23 from 2027 through 2030, and restricted stock units referenced in the footnotes vest on the same schedule.
UnitedHealth Group executive Christopher R. Zaetta received new equity awards, including 28,414 non-qualified stock options with a $282.34 per-share exercise price expiring on February 23, 2036, and a grant of 7,084 shares of common stock. On the same date, 129.454 common shares were delivered to cover tax liabilities. Following these transactions, he directly holds 16,626.54 shares of UnitedHealth common stock. Footnotes state that restricted stock units and the non-qualified options vest 25% annually each February 23 from 2027 through 2030.
UNITEDHEALTH GROUP INC executive Timothy John Noel reported new equity awards and a small tax-related share disposition. He received 35,517 non-qualified stock options and 8,855 shares of common stock as grants. The options and the related restricted stock units vest 25% each year on February 23 from 2027 through 2030. To satisfy tax obligations, 123.171 shares of common stock were disposed of at $282.34 per share, leaving him with 17,472.324 common shares directly owned.
UNITEDHEALTH GROUP executive Erin McSweeney reported new equity awards and a related tax share disposition. She was granted 19,535 non-qualified stock options with an exercise right, and 4,871 shares of common stock as a stock award. The filing also shows 130.684 shares of common stock were disposed of at $282.34 per share to satisfy tax withholding obligations. Both the restricted stock units referenced in the footnotes and the non-qualified stock options vest 25% each year on February 23 from 2027 through 2030, spreading the compensation over four years.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported equity compensation and a related tax share disposition. He was granted 35,517 non-qualified stock options with an exercise right to buy shares, and 8,855 shares of common stock as a stock award. Both awards vest in four equal installments of 25% on February 23 of each year from 2027 through 2030. To satisfy tax obligations on equity, 178.988 shares of common stock were disposed of at $282.34 per share, leaving him with 18,479.97 common shares held directly after these transactions.
DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group’s Chief Financial Officer Wayne S. DeVeydt reported equity awards that increase his direct ownership in the company. He was granted non-qualified stock options for 35,517 shares on February 23, 2026, and a separate award of 8,855 shares of common stock at $282.34 per share.
The common stock award and related restricted stock units vest in 25% increments each February 23 from 2027 through 2030. The stock options follow the same vesting schedule, also vesting 25% annually on those dates. These awards are classified as grants or awards rather than open-market purchases.
UnitedHealth Group executive Erin McSweeney reported two insider transactions involving company common stock. On February 20, 2026, she disposed of 136.641 shares and 155.182 shares at $290.00 per share, both coded as F transactions, meaning shares were withheld to cover tax liabilities rather than sold on the open market.
UnitedHealth Group executive Christopher R. Zaetta reported two tax-related share dispositions. On February 20, 2026, he surrendered 130.851 and 312.436 shares of UnitedHealth common stock at a stated value of $290 per share to cover taxes by delivering shares rather than paying cash.
After these withholding transactions, his directly held balances reported in the filing were 9,984.430 shares following the first disposition and 9,671.994 shares following the second, reflecting routine administrative adjustments tied to equity compensation.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported two Form 4 transactions involving common stock. On February 20, 2026, he disposed of 249.6400 and 254.9080 shares at $290.00 per share as tax-withholding dispositions, meaning shares were withheld to cover tax obligations rather than sold on the open market. After these transactions, his directly owned common stock holdings were reported at 9,803.9580 shares.
UNITEDHEALTH GROUP INC executive Timothy John Noel reported tax-related share dispositions under a Form 4. On February 20, 2026, he used 152.599 and 311.958 shares of common stock, each at $290.00 per share, to cover tax obligations. After these non-market transactions, he directly owned 8,740.495 common shares.
UnitedHealth Group Chief Accounting Officer Thomas E. Roos reported two tax-withholding share dispositions tied to equity compensation. On February 20, 2026, he surrendered a total of 326.067 shares of common stock in transactions coded “F” at $290.0000 per share to cover tax liabilities, leaving him with 28,999.418 shares of UnitedHealth common stock held directly.
ROOS THOMAS E reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 322 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 29,325 shares.
Zaetta Christopher R reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 213 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 10,115 shares.
McSweeney Erin reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 153 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 11,040 shares.
UnitedHealth Group Chief Executive Officer, UHC, Timothy John Noel reported a tax-related share disposition under a Form 4. On 02/13/2026, 125.616 shares of UnitedHealth Group common stock were used to cover tax withholding at a price of $293.19 per share. Following this tax-withholding disposition, he directly owned 9,205.052 shares of common stock.
UnitedHealth Group executive Patrick H. Conway, Chief Executive Officer of Optum, reported a tax-related share disposition. On February 13, 2026, a Form 4 shows a code F tax-withholding disposition of 295.409 shares of UnitedHealth Group common stock at $293.19 per share. After this transaction, Conway directly beneficially owned 10,308.506 shares of common stock.
UnitedHealth Group director equity compensation reported
A Form 4 reports that director Paul R. Garcia received equity-based compensation from UnitedHealth Group Inc. (UNH) on 01/02/2026. The filing shows a grant of 168 deferred stock units at a price of $0, described as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be held until his Board service ends. The filing also shows a separate grant of 112 shares of common stock at $0, also as regular quarterly director compensation. Following these transactions, he beneficially owns UnitedHealth Group common stock directly and indirectly, including shares held through several trusts.
UnitedHealth Group director reports quarterly equity compensation grant
A UnitedHealth Group director reported receiving 285 shares of common stock on 01/02/2026 at a price of $0, reflecting a grant of deferred stock units as regular quarterly compensation for Board service. After this grant, the director beneficially owns 10,160 shares directly and 6,033 shares indirectly through a trust. The deferred stock units are immediately vested but must be held until the director’s service on the Board is completed.
UnitedHealth Group reported an insider equity transaction involving one of its directors. On 01/02/2026, the director received 168 shares of common stock, described as a regular quarterly compensation grant for board service. The shares were acquired at a stated price of $0, reflecting that they are part of non-cash director compensation rather than an open-market purchase.
Following this grant, the director beneficially owns 2,075 shares of UnitedHealth Group common stock directly and 3,800 shares indirectly through a trust. The filing records the transaction as an acquisition of common stock and confirms it is being reported by a single reporting person.
UnitedHealth Group director reports quarterly equity compensation. Director John H. Noseworthy M.D., a board member of UnitedHealth Group Inc., reported receiving 261 shares of common stock on 01/02/2026 at a stated price of $0.
According to the disclosure, these are deferred stock units granted as regular quarterly compensation for service as a director. The units are immediately vested but must be held until the director’s service on the Board is completed. After this grant, the director beneficially owns 6,997 shares directly.
UnitedHealth Group director reports quarterly equity grant
A director of UnitedHealth Group received 279 deferred stock units of common stock on 01/02/2026 as regular quarterly compensation for Board service. These deferred stock units vest immediately but must be held until the director’s service on the Board is completed. Following this grant, the director beneficially owns a total of 7,219 shares or units of UnitedHealth Group common stock, held directly.
UnitedHealth Group director reports quarterly deferred stock grant
A UnitedHealth Group director reported receiving 125 deferred stock units of common stock on January 2, 2026 as regular quarterly compensation for Board service. The filing states these deferred stock units are immediately vested but must be held until the director completes service on the Board. After this grant, the director beneficially owns 125 shares in direct form.
UnitedHealth Group director Michele J. Hooper reported receiving 168 deferred stock units of UnitedHealth Group common stock on 01/02/2026 as regular quarterly compensation for service on the Board. These deferred stock units were granted at a price of $0, are immediately vested, and must be retained until she completes her service as a director. Following this grant, she beneficially owns 41,294 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director reports quarterly stock compensation. Director Frederick William McNabb III received 316 deferred stock units of UnitedHealth Group common stock on 01/02/2026 at a price of $0, reflecting regular quarterly compensation for board service. Following this grant, he beneficially owns 14,710 shares/units of common stock.
The filing explains that these deferred stock units are immediately vested but must be held until the director completes service on the Board. The report is filed as a Form 4 by a single reporting person and reflects a routine equity-based compensation award for a non-employee director.
UnitedHealth Group Inc. director Charles D. Baker reported a routine equity compensation transaction. On 01/02/2026, he acquired 279 deferred stock units of UnitedHealth Group common stock at a price of $0 per unit. These deferred stock units are granted as regular quarterly compensation for service as a director and are immediately vested, but must be retained until he completes his service on the Board. Following this grant, he beneficially owns 1,806 shares/deferred stock units on a direct basis.
UnitedHealth Group CEO and director Stephen J. Hemsley reported a gift of company stock. On 12/19/2025, he conveyed 55,000 shares of UnitedHealth Group common stock as a gift at a reported price of $0. After this transaction, he beneficially owned 372,947.942 shares directly. He also held 351.9396 shares indirectly through a 401(k) plan and 681,875 shares indirectly through trusts. The filing indicates this was a personal share transfer rather than an open‑market sale.
UnitedHealth Group executive reports routine share accrual from dividends. Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a unit of UnitedHealth Group Inc.), reported acquiring 44.329 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains this represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest.
These shares were acquired at a price of $0, reflecting that they are dividend-related accruals rather than open-market purchases. Following this transaction, Noel directly beneficially owns 9,330.668 shares of UnitedHealth Group common stock.
UnitedHealth Group director reports stock credited from dividend equivalents. On 12/16/2025, a director of UnitedHealth Group Inc. received 43 shares of common stock at a price of $0. These shares represent dividend equivalents paid on vested deferred stock units, and are immediately vested under the same terms as the underlying deferred stock units.
Following this transaction, the director beneficially owns 6,940 shares of UnitedHealth Group common stock in direct form.
UnitedHealth Group executive reports routine share accrual tied to awards
UnitedHealth Group executive Erin L. McSweeney, EVP & Chief People Officer, reported an acquisition of 38.566 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains that this amount represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest. After this transaction, McSweeney beneficially owned a total of 11,192.638 shares of common stock in direct form.
UnitedHealth Group director reports receipt of dividend equivalents in stock. A director of UnitedHealth Group Inc. received 11 shares of common stock on 12/16/2025 at a reported price of $0. The filing explains that these shares represent dividend equivalents paid on vested deferred stock units, and that the dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. Following this transaction, the director beneficially owns 1,527 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group CEO and director Stephen J. Hemsley reported a routine insider transaction involving dividend equivalents on his deferred stock units. On 12/16/2025, he acquired 52 shares of common stock at a price of $0, reflecting dividend equivalents that are immediately vested and subject to the same terms as the underlying deferred stock units.
Following this transaction, Hemsley beneficially owns 427,947.942 shares of UnitedHealth Group common stock directly. He also reports indirect ownership of 351.9396 shares through a 401(k) and 681,875 shares through trusts. The filing reflects an incremental increase tied to existing equity compensation rather than an open-market purchase.
UnitedHealth Group director reports small stock accrual from dividends
A UnitedHealth Group Inc. director, Frederick William McNabb III, reported receiving 53 shares of UnitedHealth Group common stock on 12/16/2025. The filing states these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. The transaction was recorded at a price of $0 per share, reflecting that no cash was paid by the director for these shares.
Following this transaction, the director beneficially owns 14,394 shares of UnitedHealth Group common stock in direct ownership. The form was filed as a single-reporting-person Form 4 and signed by an attorney-in-fact on behalf of the director.
UnitedHealth Group director John H. Noseworthy, M.D. reported a small increase in his holdings of UnitedHealth Group common stock. On 12/16/2025, he acquired 43 shares at a price of $0, described as dividend equivalents paid on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units. Following this transaction, he beneficially owns 6,736 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director Kristen L. Gil reported a small change in her holdings of UnitedHealth Group common stock. On 12/16/2025, she acquired 7 shares of common stock at a price of $0, recorded as dividend equivalents paid on vested deferred stock units. After this transaction, she beneficially owned 1,907 shares directly and 3,800 shares indirectly through a trust. The dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.
UnitedHealth Group executive Christopher R. Zaetta, EVP & Chief Legal Officer, reported acquiring additional UnitedHealth Group common stock through dividend equivalents on restricted stock units. On 12/16/2025, he acquired 44.528 shares at a price of $0, reflecting reinvested dividends rather than an open-market purchase. These dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and are forfeited if those units do not vest. Following this transaction, Zaetta beneficially owns 10,327.804 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group insider Patrick H. Conway, Chief Executive Officer of Optum, reported an increase in his holdings of company common stock through dividend equivalents on restricted stock units. On 12/16/2025, he acquired 67.721 shares at a price of $0, reflecting stock dividends credited on his outstanding restricted stock units. After this transaction, he beneficially owned 10,603.915 shares of UnitedHealth Group common stock in direct ownership. The filing notes that these dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest.
UnitedHealth Group reported an insider equity update for its Chief Financial Officer. On 12/16/2025, the CFO acquired 70.042 shares of UnitedHealth Group common stock at a price of $0. These shares represent dividend equivalents credited on outstanding restricted stock units, meaning additional shares were granted in lieu of cash dividends on those units.
Following this transaction, the CFO beneficially owns 10,661.941 shares of UnitedHealth Group common stock in direct ownership. The dividend-equivalent shares are subject to the same vesting and forfeiture conditions as the underlying restricted stock units.
UnitedHealth Group Inc. director Timothy P. Flynn reported a small increase in his holdings of the company’s common stock through an insider transaction dated 12/16/2025. The filing shows an acquisition of 65 shares of common stock at a stated price of $0, described as dividend equivalents paid on vested deferred stock units that are immediately vested and follow the same terms as the underlying units.
After this transaction, Flynn beneficially owned 9,875 shares of UnitedHealth Group common stock directly and 6,033 shares indirectly through a trust. The form is filed for one reporting person and is signed by an attorney-in-fact on Flynn’s behalf.
UnitedHealth Group director reports additional stock via dividend equivalents. Director Michele J. Hooper reported acquiring 249 shares of UnitedHealth Group common stock on 12/16/2025 at a price of $0 per share. These shares represent dividend equivalents paid on vested deferred stock units and are immediately vested, carrying the same terms as the underlying deferred stock units. Following this transaction, she beneficially owns 41,126 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director reports small stock-related award. A UnitedHealth Group Inc. director reported receiving 13 shares of common stock on 12/16/2025 as dividend equivalents on vested deferred stock units, at a stated price of $0. These dividend equivalents vest immediately and follow the same terms as the underlying deferred stock units. After this transaction, the director holds 3,034 UnitedHealth Group shares directly, and additional indirect holdings of 2,146 shares through a revocable trust, 45 shares through one trust, and 55 shares through another trust.
UnitedHealth Group’s Chief Accounting Officer, Thomas E. Roos, reported an automatic increase in his holdings of company common stock. On 12/16/2025, he acquired 23.408 shares of common stock at a price of $0, coded as an acquisition, bringing his total directly held beneficial ownership to 29,642.927 shares.
The filing explains that these additional shares represent dividend equivalents credited on outstanding restricted stock units. These dividend equivalents follow the same vesting conditions as the underlying restricted stock units and will be forfeited if those units do not vest, meaning the added shares are still subject to performance or service-based requirements.
Frederick W. McNabb III, a director of UnitedHealth Group Inc. (UNH), reported receipt of 289 deferred stock units as compensation on 10/01/2025. The units were issued at $0 and are immediately vested but must be retained until he leaves the Board. Following the grant, Mr. McNabb beneficially owns 14,341 shares (direct). The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Timothy P. Flynn, a director of UnitedHealth Group Inc. (UNH), received 272 deferred stock units on 10/01/2025 as regular quarterly director compensation at a reported price of $0. The filing shows 9,810 shares beneficially owned following the transaction and an additional 6,033 shares held indirectly by trust. The form explains these deferred stock units are immediately vested but must be retained until the director leaves the board. The Form 4 was signed by an attorney-in-fact and dated 10/03/2025.
UnitedHealth Group (UNH) director Kristen L. Gil received 162 shares of common stock as regular quarterly director compensation on 10/01/2025 at no cash price reported. After the grant, Ms. Gil directly beneficially owns 1,900 shares and indirectly owns 3,800 shares through a trust. The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing identifies the reporting person as a director and notes the shares were granted as routine director compensation.